Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Milestone Achieved

4 Jan 2007 07:00

ViaLogy PLC04 January 2007 ViaLogy plc ("ViaLogy" or "the Company") Milestone Achieved Completion of Key Milestone on Multi-parallax Exploitation ("MPEX") ElectronicEye(TM)Program with Boeing Phantom Works LONDON, Jan 2 -- ViaLogy plc (LSE: VIY), a leading innovator of real-timenetwork-centric signal processing platforms for sensor-intensive applications,announced today that it has successfully completed the Critical Design Review("CDR") Milestone on the Multi-parallax Exploitation ("MPEX") Electronic EyeTMProgram with Boeing Phantom Works ("Boeing") in Huntington Beach, CA, USA. The Electronic Eye(TM)program was initiated in direct response to emergingprecision detection requirements in next-generation missile detection anddefense systems (seekers) and panoramic airspace surveillance platforms. Underthe joint program with Boeing, ViaLogy's core signal processing technology -Quantum Resonance Interferometry ("QRI") - is providing the basic engine forpowering the silicon electronic-eye based on vision constructs found in insectsand reptiles. Vialogy has a patent pending on the MPEX Electronic Eye(TM)and itsapplications. Currently, most advanced vision systems are limited to only stereo vision with asingle parallax based on the co-registration of frames from two eyes, allowingonly a scan of the horizon. In contrast, MPEX Electronic Eye(TM)is exploitingmultiple parallaxes to achieve panoramic or 360-degree viewing capability andthree dimensional perception using multiple, overlapping fields-of-view. Thisconstruction dramatically increases the probability of target detection andlocalization. Dr. Edward McCullough, Principal Scientist in advanced aero analysis at BoeingPhantom Works, commented: "I am very excited by ViaLogy's rapid progress andnovel approach on the MPEX Electronic Eye(TM) Researchers have been studying thecomputational architectures, functions, mechanisms, and principles of visualperception underlying biological systems for over three decades to find ways toimplement them. We have specific near-term and long-term interests in thistechnology to support our defense, homeland security and space program needs." ViaLogy's Chief Technology Officer, Dr. Sandeep Gulati said: "We are buildingupon seminal work conducted by Dr. McCullough and his team in the area ofbiomimetic-based advanced autonomy for future planetary rovers and spaceoperations. Our core technology provides a near-term opportunity for overcomingsome of the fundamental information processing and system engineering challengesin implementing multi-parallax construction to address practicalomni-directional surveillance applications. MPEX has been developed as aplatform technology in its own right and we are now making good progress inadapting it for specific applications." ViaLogy's initial MPEX Electronic Eye(TM)applications are geared to detection ofvery fast moving targets such as in missile interceptors, deployment on fastmoving ground vehicles and airborne platforms such as UAVs (unmanned aerialvehicles), and omni-directional tower mounts for border surveillance andcritical infrastructure security. Commenting on the achievement of this milestone, ViaLogy's CEO, Michael Kelly,said: "MPEX is very well aligned with the ViaLogy business model. We can applyour unique expertise and sensor-agnostic signal processing technology tocommercial off-the-shelf hardware and sensors to deliver enhanced performance ata fraction of the cost of comparable systems especially designed for militaryapplications." Next steps in the Boeing collaboration include a demonstration of the use ofMPEX Electronic Eye(TM)engineering for detection of ground-based border intrusionevents, and an aerial payload for low altitude UAVs. Successful operationaldemonstration of the proprietary MPEX technology could lead to its use in anumber of future defense and homeland security programs. For further information please contact: ViaLogyMichael Kelly, CEO - US +1 626 296 6337Terry Bond, Chairman - UK & Europe +44 (0)20 2869 7014 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor (intensive) applications. ViaLogy is currently deployingand designing computational systems, powered by its patented technologies, forapplications in life sciences, public safety and security, surveillance, defenseand geoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied by such forward-looking statements. Such factors include generaleconomic and business conditions, the ability to acquire and develop specificprojects, the ability to fund operations and changes in consumer and businessconsumption habits and other factors over which ViaLogy has little or nocontrol. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Jul 20097:00 amRNSContract Win
23rd Jun 20093:06 pmRNSAdditional Listing
12th Jun 200910:55 amRNSBoard Change
1st Jun 200912:39 pmRNSExercise of Options & TVR
11th May 20094:10 pmRNSHolding(s) in Company
6th May 20094:04 pmRNSTrading Statement
5th May 20094:13 pmRNSHolding(s) in Company
5th May 20093:24 pmRNSExercise of Warrants
5th May 20097:00 amRNSTrading Statement
23rd Apr 20098:55 amRNSTrading Statement
21st Apr 200912:50 pmRNSResult of Warrantholder General Meeting
16th Apr 20098:49 amRNSTrading Statement
6th Apr 200911:56 amRNSHolding(s) in Company
2nd Apr 20097:00 amRNSIssue of Equity
1st Apr 20098:10 amRNSTrading Statement
23rd Mar 20097:00 amRNSTrading Statement
4th Mar 20091:33 pmRNSHolding(s) in Company
16th Jan 20098:31 amRNSTrading Statement
18th Dec 20089:19 amRNSWarrant Update
16th Dec 20087:00 amRNSTrading Statement
16th Dec 20087:00 amRNSHalf Yearly Report
29th Oct 200812:47 pmRNSResult of AGM
29th Oct 20087:00 amRNSOil Well Update
22nd Oct 20087:00 amRNSOil Exploration Drilling in Texas
7th Oct 200810:55 amRNSCancellation and re-issue of options
30th Sep 20087:00 amRNSFinal Results
29th Sep 20087:00 amRNSProjects Update
10th Sep 20089:00 amRNSHolding(s) in Company
1st Sep 200811:12 amRNSTotal Voting Rights
19th Aug 20084:14 pmRNSHolding(s) in Company
19th Aug 200812:40 pmRNSPlacing raises GBP1.8 million
18th Aug 200810:07 amRNSContract with ASTFS
14th Aug 200811:07 amRNSStrategic Agreement with Swan
6th Aug 20087:00 amRNSLA County Radiation Monitorin
21st Jul 20087:00 amRNSUpdate on Oil Reservoir Analy
17th Jul 20082:26 pmRNSHolding(s) in Company
1st Jul 20087:00 amRNSPartners with Texas group AST
18th Jun 20087:00 amRNSPartners with Atascosa Explor
29th May 20087:00 amRNSContract Win
1st Apr 20081:00 pmRNSViaLogy selected by Cisco
13th Mar 20082:10 pmRNSAdditional Listing
8th Feb 200810:02 amRNSAppointment of Broker
7th Feb 20087:00 amRNSProduct approval in US
30th Jan 20087:01 amRNSSenior Appointment
27th Dec 20077:00 amRNSInterim Results
30th Nov 20077:11 amRNSSenior appointment
30th Oct 20074:13 pmRNSResult of AGM
30th Oct 200710:02 amRNSAGM Statement
25th Oct 200710:59 amRNSGrant of options
28th Sep 20074:15 pmRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.